We are live on ! Find out more
AVNS icon

Avanos Medical

288 hedge funds and large institutions have $1.1B invested in Avanos Medical in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 74 increasing their positions, 79 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $68K | Put options by funds: $35K

60% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 30

16% more capital invested

Capital invested by funds: $942M → $1.1B (+$154M)

5% more funds holding

Funds holding: 274288 (+14)

0.2% more ownership

Funds ownership: 93.02%93.22% (+0.2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 79

Holders
288
Holders Change
+14
Holders Change %
+5.11%
% of All Funds
4.63%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
48
Increased
74
Reduced
79
Closed
30
Calls
$68K
Puts
$35K
Net Calls
+$33K
Net Calls Change
+$33K
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
76
First Manhattan
New York
$934K +$159K +6,495 +23%
First Trust Advisors
77
First Trust Advisors
Illinois
$884K -$322K -13,172 -29%
PI
78
Putnam Investments
Massachusetts
$881K -$416 -17 -0.1%
SOADOR
79
State of Alaska Department of Revenue
Alaska
$876K +$4.74K +194 +0.6%
Citigroup
80
Citigroup
New York
$863K +$230K +9,409 +42%
TPSF
81
Texas Permanent School Fund
Texas
$846K -$53.2K -2,177 -7%
SFI
82
Susquehanna Fundamental Investments
Pennsylvania
$827K -$254K -10,393 -25%
CSS
83
Cubist Systematic Strategies
Connecticut
$815K -$862K -35,255 -54%
Barclays
84
Barclays
United Kingdom
$808K -$126K -5,172 -15%
YCM
85
Yousif Capital Management
Michigan
$800K -$205K -8,380 -22%
Comerica Bank
86
Comerica Bank
Texas
$792K -$222K -9,067 -25%
American Century Companies
87
American Century Companies
Missouri
$747K +$110K +4,486 +19%
Deutsche Bank
88
Deutsche Bank
Germany
$700K +$33K +1,350 +6%
TI
89
Trexquant Investment
Connecticut
$693K +$274K +11,186 +78%
JAM
90
Jupiter Asset Management
United Kingdom
$690K +$302K +12,354 +94%
MIM
91
MetLife Investment Management
New Jersey
$682K
AIG
92
American International Group
New York
$681K -$4.84K -198 -0.8%
FNBOO
93
First National Bank of Omaha
Nebraska
$671K -$58K -2,371 -9%
Truist Financial
94
Truist Financial
North Carolina
$626K +$565K +23,124 New
UBS Group
95
UBS Group
Switzerland
$622K -$2.35K -96 -0.4%
PAM
96
Panagora Asset Management
Massachusetts
$606K -$182K -7,436 -25%
TL
97
Tradewinds LLC
North Carolina
$598K +$61.3K +2,505 New
LSERS
98
Louisiana State Employees Retirement System
Louisiana
$598K -$2.44K -100 -0.5%
NSAM
99
North Star Asset Management
Wisconsin
$591K +$3.1K +127 +0.6%
Renaissance Technologies
100
Renaissance Technologies
New York
$584K +$528K +21,600 New

AVNS Hedge Fund Activity: Q4 2022 in Review

288 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2022, worth a combined $1.1B — up 16% from $942M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new AVNS positions and 30 closed out — a net gain of 18 holders — while 74 added to existing stakes and 79 trimmed.

The largest buyer was Westwood Holdings Group, adding an estimated $11.5M. The largest seller was Millennium Management, cutting an estimated $19.6M.

  • 288 institutional investors held Avanos Medical (AVNS) as of Q4 2022, up from 274 in Q3 2022.
  • Funds reported $1.1B of Avanos Medical stock for Q4 2022, up 16% quarter-over-quarter.
  • 48 funds opened new Avanos Medical positions in Q4 2022 and 30 closed out, a net change of +18 holders.
  • The largest Avanos Medical buyer in Q4 2022 was Westwood Holdings Group, an estimated $11.5M added.
  • The largest Avanos Medical seller in Q4 2022 was Millennium Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q4 2022.